Pfizer Corporation

Pfizer Products Inc.

Douglas James Critcher

David Morris Gethin

Denis Billen

Kim Thomas Hall

Graham Michael Kyne

Jessica Boyle

Christelle Lauret

Nigel Derek Arthur Walshe

James John Eshelby

Bernard Joseph Banks

Stephen Paul Gibson

Peter Robert Rose

Christopher J Dutton

Nigel D Walshe

Ivan Tommasini

Graham Lunn

Yong Tao

Richard Edward Armer

Darren John Schulz

Nathan Anthony Chubb

Kimberley Verrier

Kevin Paul Girard

Anthony Logan Chubb

Andrew J Rudge

Brian Matthew Samas

David Sydney Bernard Daniels

Gregory Scott Goeken

Paul H Wiedenau

David H Williams

Paul Heinrich Wiedenau

David Howard Williams

Andrew John Rudge

Nigel Derek Walshe

The present invention discloses a novel p-toluenesulfonic acid salt and a crystalline polymorphic Form 1 of said salt of 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one, pharmaceutical composition containing the same, as well as preparations and uses thereof. The present invention also discloses a novel phosphoric acid salt of 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one, pharma-ceutical composition containing the same, as well as preparations and uses thereof.

Pyrrolo[2,3-d]pyrimidine tosylate salt, crystalline form thereof and manufacturing process and intermediates thereto

This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.

Substituted arylpyrazoles

The invention relates to a sulfonamide compound of formula (I) or a pharmaceutically, veterinarily or agriculturally acceptable salt or solvate thereof, where the groups R-Rare described in the description, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides. 

N-(1-arylpyrazol-4L)sulfonamides and their use as parasiticides

N-(1-arylpyrazol-4l) sulfonamides and their use as parasiticides

The present invention relates to novel terpene alkaloids and their use as antiparasitic agents. The present invention also relates to an antiparasitic agent which comprises a terpene alkaloid compound of this invention as an effective ingredient in an antiparasitic formulation. More particularly, the present invention relates to derivatives of the terpene alkaloid (1S,2R,4aS,5R,8R,8aR)-2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(1-methylethenyl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl (2S,3aR,9bR)-6-chloro-9b-hydroxy-5-methyl-1,2,3,3a,5,9b-hexahydropyrrolo[2,3-c][2,1]benzoxazine-2-carboxylate. Pharmaceutical compositions comprising the same are also disclosed.

Antiparasitic terpene alkaloids

4-arylpiperidine derivatives for the treatment of pruritus

Pyridazine endothelin antagonists

Growing community of inventors

Sandwich, United Kingdom

Douglas James Critcher